RBC Capital Maintains Outperform on Axonics, Lowers Price Target to $75
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an 'Outperform' rating on Axonics (NASDAQ:AXNX) but lowered the price target from $85 to $75.
July 12, 2023 | 3:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Axonics' price target has been lowered from $85 to $75 by RBC Capital, though the 'Outperform' rating is maintained.
The lowering of the price target by RBC Capital could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100